30.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BEAM Giù?
Forum
Previsione
Beam Therapeutics Inc Borsa (BEAM) Ultime notizie
Baillie Gifford & Co. Boosts Beam Therapeutics Stake by 40% - National Today
Beam Therapeutics CEO Sells 30,078 Shares in April 2026 Transaction | Stock UpdateNews and Statistics - IndexBox
Beam Therapeutics' CEO Sold Over 30,000 Company Shares. Here's What This Means for Investors. - Yahoo Finance
Beam Therapeutics' CEO Sold Over 30,000 Company Shares. Here's What This Means for Investors. - The Motley Fool
BofA Securities Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $47 - Moomoo
BEAM Price Today: Beam Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Beam Therapeutics President Sells $290,289 in Stock - National Today
(BEAM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Beam Therapeutics CEO Sells Over $700K in Stock - National Today
BEAM Forecast, Price Target & Analyst Ratings | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill
Beam Therapeutics Insider Sells $146K in Shares - National Today
JonesTrading Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $35 - Moomoo
Beam Therapeutics CEO Evans sells $739k in stock By Investing.com - Investing.com Australia
Amy Simon, Beam Therapeutics CMO, sells $164,686 in stock By Investing.com - Investing.com India
Beam Therapeutics (NASDAQ:BEAM) Insider Amy Simon Sells 6,700 Shares of Stock - MarketBeat
John Evans Sells 30,078 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat
Beam Therapeutics (NASDAQ:BEAM) Insider Christine Bellon Sells 5,956 Shares - MarketBeat
Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock By Investing.com - Investing.com Australia
Beam Therapeutics president sells $290k in shares By Investing.com - Investing.com Australia
Beam Therapeutics CEO Evans sells $739k in stock - Investing.com
Amy Simon, Beam Therapeutics CMO, sells $164,686 in stock - Investing.com
Beam Therapeutics president sells $290k in shares - Investing.com
[Form 4] Beam Therapeutics Inc. Insider Trading Activity - Stock Titan
Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock - Investing.com
Beam Therapeutics (BEAM) CMO covers tax obligations via 6,700-share sale - Stock Titan
Beam Therapeutics (BEAM) SVP auto-sells shares to cover RSU tax obligations - Stock Titan
Beam Therapeutics (BEAM) CLO auto-sells 5,956 shares for RSU tax withholding - Stock Titan
Beam Therapeutics (BEAM) president’s 11,810-share sale covers RSU taxes - Stock Titan
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Evans John M. - Moomoo
BEAM SEC FilingsBeam Therapeutics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Beam Therapeutics Inc. (BEAM) Stock Price, News, Quote & History - Yahoo! Finance Canada
SG Americas Securities LLC Boosts Beam Therapeutics Stake by 139% - National Today
SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat
Beam Therapeutics Inc. (BEAM) stock price, news, quote and history - Yahoo Finance Australia
Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Beam Therapeutics Inc. (BEAM) interactive stock chart - sg.finance.yahoo.com
Beam Therapeutics (NASDAQ: BEAM) awards 20,000 RSUs to Chief Legal Officer - Stock Titan
Beam Therapeutics (BEAM) awards 20,000 RSUs to SVP Bethany Cavanagh - Stock Titan
Beam Therapeutics (BEAM) awards 31,750 RSUs to Chief Medical Officer Amy Simon - Stock Titan
CFO of Beam Therapeutics (NASDAQ: BEAM) awarded 31,750 RSUs - Stock Titan
Beam Therapeutics (BEAM) grants president 40,000 restricted stock units - Stock Titan
Beam Therapeutics (BEAM): Among the stocks that could 10x over the next 5 years - MSN
Insider Selling: Beam Therapeutics (NASDAQ:BEAM) CEO Sells 25,000 Shares of Stock - MarketBeat
Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years - Yahoo Finance
Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing - Moomoo
Beam Therapeutics shares climb after positive BEAM-302 trial update - MSN
Beam (BEAM) Reports Promising Data from BEACON Trial in Sickle C - GuruFocus
Beam Therapeutics publishes sickle cell therapy trial data By Investing.com - Investing.com Australia
Why Is BEAM Stock Edging Higher After Hours Today? - Stocktwits
Beam Therapeutics CEO Evans sells $1.1m in stock By Investing.com - in.investing.com
Beam Therapeutics CEO Evans sells $1.1m in stock - Investing.com
Beam Therapeutics (BEAM) CEO sells 50K shares, gains 90K RSUs - Stock Titan
Beam Therapeutics publishes sickle cell therapy trial data - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):